DGS Capital Management’s Dr. Reddy's Laboratories RDY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $1.18M | Buy |
74,993
+15,308
| +26% | +$242K | 0.3% | 56 |
|
|
2024
Q3 | $948K | Buy |
59,685
+1,810
| +3% | +$28.8K | 0.26% | 75 |
|
|
2024
Q2 | $882K | Buy |
57,875
+8,265
| +17% | +$126K | 0.25% | 74 |
|
|
2024
Q1 | $728K | Buy |
49,610
+6,530
| +15% | +$95.8K | 0.21% | 91 |
|
|
2023
Q4 | $600K | Buy |
43,080
+4,590
| +12% | +$63.9K | 0.23% | 85 |
|
|
2023
Q3 | $515K | Buy |
38,490
+3,555
| +10% | +$47.5K | 0.25% | 91 |
|
|
2023
Q2 | $441K | Buy |
34,935
+1,075
| +3% | +$13.6K | 0.22% | 107 |
|
|
2023
Q1 | $386K | Sell |
33,860
-50
| -0.1% | -$569 | 0.21% | 104 |
|
|
2022
Q4 | $351K | Buy |
33,910
+1,910
| +6% | +$19.8K | 0.23% | 110 |
|
|
2022
Q3 | $335K | Buy |
32,000
+1,640
| +5% | +$17.2K | 0.22% | 102 |
|
|
2022
Q2 | $336K | Buy |
30,360
+8,680
| +40% | +$96.1K | 0.27% | 88 |
|
|
2022
Q1 | $242K | Buy |
21,680
+3,665
| +20% | +$40.9K | 0.15% | 152 |
|
|
2021
Q4 | $236K | Buy |
+18,015
| New | +$236K | 0.15% | 132 |
|